🇺🇸 FDA
Patent

US 9446075

Compositions derived from stem cell released molecules and methods for formulation thereof

granted A61KA61K2800/74A61K35/12

Quick answer

US patent 9446075 (Compositions derived from stem cell released molecules and methods for formulation thereof) held by BIOREGENERATIVE SCIENCES, INC. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOREGENERATIVE SCIENCES, INC.
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2800/74, A61K35/12, A61K35/28, A61K35/33